A Clinical Trial of Intratumoural Hypoxia and Its Biologic Correlates in Patients Undergoing Surgical Resection of Localized Pancreatic Cancer, Using Pre-operative Administration of the Hypoxia Marker Pimonidazole.
This study involves the administration of a hypoxia marker, pimonidazole hydrochloride,
taken orally approximately 24 hours before surgical resection of a pancreatic tumour in order
to identify areas of lower oxygen content on tumour samples.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society